J&J Offers To Help Shape Terms Of CMS Practical Clinical Trial Agenda
This article was originally published in The Gray Sheet
Executive Summary
Industry should work with CMS to establish a priority list to determine which technologies are best suited for practical clinical trials (PCTs), according to Johnson & Johnson VP-Health Policy & Government Affairs Kathy Buto